Humana Sale of investments decreased by 72.6% to $395.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 24.3%, from $522.00M to $395.00M. Over 4 years (FY 2021 to FY 2025), Sale of investments shows an upward trend with a 16.4% CAGR.
High proceeds may indicate active portfolio rebalancing or a strategy to lock in investment gains.
Represents the cash inflows from the sale of debt securities classified as available-for-sale. This reflects the company...
Standard metric for insurance companies with large investment portfolios.
other_proceeds_from_sale_of_available_for_sale_securities_debt| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $468.00M | $499.00M | $627.00M | $1.29B | $69.00M | $616.00M | $455.00M | $50.00M | $761.00M | $4.00M | $2.98B | $391.00M | $108.00M | $1.26B | $1.62B | $522.00M | $721.00M | $3.82B | $1.44B | $395.00M |
| QoQ Change | — | +6.6% | +25.7% | +106.4% | -94.7% | +792.8% | -26.1% | -89.0% | >999% | -99.5% | >999% | -86.9% | -72.4% | >999% | +28.5% | -67.7% | +38.1% | +430.2% | -62.2% | -72.6% |
| YoY Change | — | — | — | — | -85.3% | +23.4% | -27.4% | -96.1% | >999% | -99.4% | +554.9% | +682.0% | -85.8% | >999% | -45.7% | +33.5% | +567.6% | +203.7% | -10.8% | -24.3% |